Surprising no one has commented on the subject thread Most...

First 2 Last

Share
Profile

Follow
antibotter

7,521 Posts.

263

18/03/19

16:37

Post #: 37800543
Share

Originally posted by antibotter ↑

It has been some time since I put serious input into the Starpharma forum.

So here goes.

More than a decade ago Starpharma started on a journey to develop VivaGel^™ BV formulation with active ingrediant SPL7013

Conducting nine trials up until now and bankrolling these tests to the tune of over a AU$100 million with the knowledge of enormous untapped demand globally , any sane person (including those on this forum),would think the strategy of company to be sound.

We had a SPA in place.
We had Fast Track status in places
We had Qualified Infectious Disease Production designation in place
We handed the FDA a 110,000 page NDA document - which was a culmination of many years work
We had open communications with the FDA......so there would be no surprises
A couple of weeks before PDUFA announcement we had a licensee who was going to put AU$28 million upfront on approval of FDA for the NDA in Starpharma's bank account and the balance of AU$114 million in milestones and inflection points

So what could go wrong

Nothing

Starpharma management were so confident of a positive outcome. I was 100% confident of a positive outcome as well as I am sure..........many of the forum participants

All that has been presented on this forum into the why's was conveyed in announcements (the emails forwarded to posters recently was also presented in announcements......all it has done is reinforce the previously transmitted news)

There is no doubt in my mind as some have put on this forum.......the goal posts have changed

It is so obvious

Remember staffers that were working on the NDA......some had left and new ones had entered the arena. Why is not important....

So the biggest question I ask myself over and over and over again........if there was open communications with FDA and Starpharma over the years in regards to an adequate NDA.......

why is it at 5 minutes to midnight that the FDA say they require confirmatory clinical data (which may not necessarily mean a new clinical trial) before approval

Like a poster has previously said......Starpharma had plenty of experience of what to expect from the FDA.......the board are not novice at this.

All the i's were dotted and all the t's were crossed

Posters have said something fishy is going on here and it is not the smell coming from persons with BV

Expand

Surprising no one has commented on the subject thread

Most probably because the update came out

However I still believe it is relevant

Any takers

Love to listen to logical reasons

SPL Price at posting: $1.04 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

There are more pages in this discussion • 4 more messages in this thread...

First 2 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $43.82M

Open	High	Low	Value	Volume
10.5¢	11.5¢	10.0¢	$110.6K	1.006M

Buyers (Bids)

No.	Vol.	Price($)
1	83046	10.5¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	30000	1

View Market Depth

No.	Vol.	Price($)
1	6000	0.955
4	25073	0.950
1	3925	0.945
3	8847	0.940
1	10000	0.935

Price($)	Vol.	No.
0.960	4540	2
0.965	15000	1
0.970	13906	2
0.975	10000	1
0.980	19012	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

SPL (ASX) Chart

Surprising no one has commented on the subject thread Most...

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Banshee's historic trenches prove rich in antimony and gold for GDM

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Buyers (Bids)

Sellers (Offers)